GWP
REGN icon

Gen-Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Gen-Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Sell
172
-12
-7% -$8.17K 0.03% 322
2026
Q1 		$142K Sell
184
-6
-3% -$4.59K 0.04% 287
2025
Q4 		$147K Sell
190
-14
-7% -$9.51K 0.05% 287
2025
Q3 		$115K Buy
+204
New +$115K 0.04% 303

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Gen-Wealth Partners's REGN Position: Q2 2026 in Review

Gen-Wealth Partners reduced its Regeneron Pharmaceuticals (REGN) stake by 6.5% in Q2 2026, selling an estimated $8.17K and leaving 172 shares worth $107K. The position accounts for 0.03% of the portfolio, ranked #322.

Gen-Wealth Partners first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $147K in Q4 2025. 789 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Gen-Wealth Partners held 172 shares of Regeneron Pharmaceuticals worth $107K as of Q2 2026.
  • Gen-Wealth Partners sold 12 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.17K.
  • Regeneron Pharmaceuticals made up 0.03% of Gen-Wealth Partners's portfolio in Q2 2026, its #322 holding.
  • Gen-Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Gen-Wealth Partners's Regeneron Pharmaceuticals position peaked at $147K in Q4 2025.
  • 789 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.